Skip to content Skip to footer
Subscribe Now
NEWS

Polpharma Biologics and Libbs Farmacêutica Enter into a Licensing Agreement for an Autoimmune Biosimilar 

 Shots: 

  • Polpharma Biologics has signed a licensing agreement with Brazil-based Libbs Farmacêutica for an autoimmune biosimilar 
  • Under this strategic partnership, Polpharma Biologics is fully responsible for the development and manufacturing of the product 
  • Libbs will exclusively handle the product’s commercialization, marketing, and distribution in the Brazilian market 

Ref: Polpharma Biologics | Image: Polpharma Biologics | Press Release

Related News:- Polpharma Biologics Launches Ranivisio PFS (Biosimilar, Lucentis) in the EU

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Tags:

You May Also Like

Aquestive
April 29, 2024
Aquestive Therapeutics’ Libervan Buccal Film Receives the US FDA’s Approval to Treat Seizure Activity  
Bayar
March 18, 2025
Bayer Reports the US FDA’s sNDA Acceptance & Priority Review of Finerenone for Heart Failure (HF)
Zoetis
April 16, 2025
The US FDA Approves Zoetis’ Simparica Trio to Prevent Flea Tapeworm Infections in Dogs

Contact US

 Second Floor, H-65, Sector 63 Noida, Uttar Pradesh, INDIA – 201301

 +1 (289) 778-4900

 connect@pharmashots.com

OUR INFORMATION

About Us

Announcements

FAQ

Privacy Policy

Terms & Conditions

Grievance Redressal

FOLLOW US

Contact US

Copyright © 2018 – 2026 PharmaShots – All Rights Reserved.

We chose the name PharmaShots to reflect our mission of delivering concise, high-impact, and actionable insights — or “shots” — for decision-makers across the biopharma and healthcare ecosystem. Each story, update, or insight is designed to be sharp, focused, and easy to consume, helping readers quickly grasp what truly matters in a fast-moving industry.

PharmaShots operates at the intersection of media, insights, and brand visibility for the life sciences industry. Our core offerings include:

  • Curated biopharma and healthcare news & analysis

  • Deep-dive insight reports, lists, and industry rankings

  • Sponsored content and brand storytelling

  • Digital marketing and content distribution

  • Event and congress media partnerships

  • Interviews, viewpoints, and expert-led features

  • Newsletter sponsorships and targeted outreach

All services are designed to help companies communicate value, thought leadership, and innovation to the right audience.

PharmaShots content is created and curated by experienced healthcare writers, editors, analysts, and subject-matter contributors with strong backgrounds in biopharma, life sciences, healthcare research, and business insights.

Our editorial process focuses on clarity, accuracy, and relevance, ensuring every piece delivers insight rather than noise.

Our readers come from across the global healthcare and life sciences ecosystem, including:

  • Healthcare decision-makers

  • Biopharma and biotech professionals

  • Medtech and diagnostics leaders

  • Researchers and clinicians

  • Strategy, business development, and competitive intelligence teams

  • Investors and consultants

  • Digital health and AI innovators

  • Marketing, communications, and market access professionals

They rely on PharmaShots to stay informed, make decisions faster, and spot emerging trends early.

PharmaShots is updated daily with fresh content across news, insights, interviews, and special reports. Updates may occur daily or multiple times per week depending on industry activity, major announcements, and ongoing coverage themes.

Readers can stay connected with PharmaShots through multiple channels:

  • Subscribe to our email newsletter for curated weekly updates

  • Follow PharmaShots on LinkedIn and other social platforms

  • Visit the website regularly for new stories and reports

  • Engage with special editions, rankings, and event coverage

These channels ensure you never miss key developments shaping biopharma and healthcare.

You can reach out to PharmaShots through our website’s contact page or via email at connect@pharmashots.com for inquiries, collaborations, or feedback. Visit pharmashots.com for more details

For general inquiries, partnerships, media collaborations, or support, you can reach us at:

Email: connect@pharmashots.com

Address: PharmaShots Media Private Limited

Second Floor, H-65, Sector 63
Noida, Uttar Pradesh, India – 201301

Phone: India: +91 9582 193319 

US/Canada: +1 (289) 778-4900